Assured Investment Management’s Ionis Pharmaceuticals IONS Stock Holding History

Assured Investment Management’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-110,746	Closed	-$5.99M	–	1233
2018 Q4	$5.99M	Buy	110,746 +66,132	+148%	+$3.37M	0.17%	145
2018 Q3	$2.3M	Sell	44,614 -32,564	-42%	-$1.53M	0.04%	399
2018 Q2	$3.22M	Buy	77,178 +17,593	+30%	+$780K	0.06%	327
2018 Q1	$2.63M	Buy	59,585 +32,769	+122%	+$1.66M	0.06%	311
2017 Q4	$1.35M	Buy	+26,816	New	+$1.47M	0.03%	412
2017 Q2	–	Sell	-4,699	Closed	-$189K	–	651
2017 Q1	$189K	Buy	+4,699	New	+$211K	﹤0.01%	523
2016 Q4	–	Sell	-10,032	Closed	-$368K	–	640
2016 Q3	$368K	Sell	10,032 -12,225	-55%	-$382K	0.01%	456
2016 Q2	$518K	Buy	+22,257	New	+$718K	0.01%	401
2016 Q1	–	Sell	-1,976	Closed	-$122K	–	665
2015 Q4	$122K	Buy	+1,976	New	+$107K	﹤0.01%	531

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Assured Investment Management's IONS Position: Q1 2019 in Review

Assured Investment Management sold out of Ionis Pharmaceuticals (IONS) in Q1 2019, closing a stake of 110,746 shares — an estimated $5.99M sold.

Assured Investment Management first reported a position in IONS in Q4 2015 and held it in 9 quarters. The position peaked at $5.99M in Q4 2018. 392 funds tracked by Wall St. Rank hold IONS as of Q1 2019.

Assured Investment Management reported no remaining Ionis Pharmaceuticals position as of Q1 2019 after selling out during the quarter.
Assured Investment Management sold 110,746 Ionis Pharmaceuticals shares in Q1 2019, an estimated $5.99M.
Assured Investment Management first reported a position in Ionis Pharmaceuticals in Q4 2015 and held it in 9 quarters.
Assured Investment Management's Ionis Pharmaceuticals position peaked at $5.99M in Q4 2018.
392 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2019.

Based on Assured Investment Management's 13F filing for Q1 2019, filed 16 May 2019.